Dr Reddys Laboratories (RDY) Net Income towards Common Stockholders (2009 - 2026)
Dr Reddys Laboratories' Net Income towards Common Stockholders came in at $46.85 million for the quarter ended Jun 30, 2026, down 71.7% from $165.67 million a year earlier and down 99.9% from the prior quarter.
Dr Reddys Laboratories (RDY) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Dr Reddys Laboratories reported Net Income towards Common Stockholders of $170.69 billion, up 87.4% year-over-year; for the year ended Mar 31, 2026, it was $456 million, down 99.9% from the prior year.
- Net Income towards Common Stockholders carries a five-year compound annual growth rate of 6.9% (years ended Mar 2021 to Mar 2026).
- Going back by year, Net Income towards Common Stockholders was $337.41 billion in the year ended Mar 31, 2025, $672.67 million in the year ended Mar 31, 2024 (+19.7%), $561.73 million in the year ended Mar 31, 2023 (+41.9%) and $395.73 million in the year ended Mar 31, 2022 (+21.1%).
- The figure for the quarter ended Jun 30, 2026 represents the lowest quarterly Net Income towards Common Stockholders since the quarter ended Mar 31, 2022.
- Year-over-year, Net Income towards Common Stockholders increased in two of the last six quarters, with an average decline of 10.7%.
- The fastest year-over-year change in Net Income towards Common Stockholders over five years came in the quarter ended Mar 31, 2023 (growth of 645.5%), and the weakest in the quarter ended Mar 31, 2022 (a decline of 74.0%).
- Business Quant data shows RDY's Net Income towards Common Stockholders at $80.22 billion (quarter ended Mar 31, 2026), $90.22 billion (quarter ended Dec 31, 2025) and $200.78 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.61 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Dr Reddys Laboratories | 10.22 Bn | 9.41 Bn | 396.53 Mn | 46.85 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 46.85 Mn |
| Mar 31, 2026 | 80.22 Bn |
| Dec 31, 2025 | 90.22 Bn |
| Sep 30, 2025 | 200.78 Mn |
| Jun 30, 2025 | 165.67 Mn |
| Mar 31, 2025 | 90.51 Bn |
| Dec 31, 2024 | 221.71 Mn |
| Sep 30, 2024 | 209.55 Mn |
| Jun 30, 2024 | 166.87 Mn |
| Mar 31, 2024 | 180.13 Mn |
| Dec 31, 2023 | 207.37 Mn |
| Sep 30, 2023 | 179.04 Mn |
| Jun 30, 2023 | 214.66 Mn |
| Mar 31, 2023 | 150.60 Mn |
| Dec 31, 2022 | 200.06 Mn |
| Sep 30, 2022 | 202.28 Mn |
| Jun 30, 2022 | 158.37 Mn |
| Mar 31, 2022 | 20.20 Mn |
| Dec 31, 2021 | 123.26 Mn |
| Sep 30, 2021 | 163.51 Mn |
Dr Reddys Laboratories Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();